Patients play a vital role in finding better ways to treat cancer by participating in clinical trials. Thanks to patients who volunteered for studies, we now have a range of treatments that can cure or delay the progression of cancer for many years. Our patients are partners in care and partners in discovery.
As national leaders in the field, the University of Michigan Comprehensive Cancer Center's Skin Cancer Program provides care that builds on research and decades of outstanding success rates in the healing of all types of skin cancer -- melanoma, basal and squamous cell carcinomas, and Merkel cell carcinomas.
Over the past 30 years -- and through hundreds of clinical trials -- we've discovered better treatments so there's less chance of cancer coming back. With the help of clinical trials, we've also learned better methods of detecting cancer -- catching it earlier, when we have the best chance of curing it.
More than 190,000 women will be diagnosed with breast cancer this year. But only 5-10% of those breast cancers are caused by an inherited genetic mutation. The same gene can put women at a higher risk of ovarian cancer as well.
At the University of Michigan Comprehensive Cancer Center, doctors and scientists are committed to discovering new forms of treatment for head and neck cancer. By using the latest surgical techniques and incorporating the newest laboratory discoveries, we are able to preserve and rebuild the tissues of the mouth and throat so our patients can return to their daily lives with excellent function and quality of life.
Clinical research is a partnership between doctors and patients working to improve the treatment of cancer. Being in a clinical trial can mean trying new medicines to understand them better. Research can also mean comparing two types of cancer treatment to see which one is most effective. The ultimate goal of all clinical trials is to cure cancer and improve quality of life.
The collaborative spirit is at work here, allowing doctors and scientists to assist each other in advancing us toward better and more effective treatments for cancer. Be part of our progress. Be part of the Michigan Difference.
Adrenal cancer is rare. Exceptional patient care and innovative treatment strategies for adrenal cancer shouldn't be. At the University of Michigan Comprehensive Cancer Center, we apply the same multidisciplinary approach to diagnosing and treating adrenal cancer, and the same translational approach to basic and clinical research in the field, as we do for more prevalent cancer types.
Early Detection of Cervical Cancer Increases Survival
According to the American Cancer Society, about 12,710 new cases of invasive cervical cancer were diagnosed in 2012, with
4,220 women dying from the disease. Most cervical cancers begin in the cells lining the cervix. In general,
these can be detected through PAP tests.
Read more.
Capturing circulating cancer cells could provide insights into how disease spreads
Finding may lead to ways to prevent cancer spread.
Anti-aging gene identified as tumor suppressor in mice, research finds
Improves understanding of how tumors grow.
New drug cuts risk of deadly transplant side effect in half
Helps prevent graft-versus-host disease.
Capturing circulating cancer cells could provide insights into how disease spreads
Circulating tumor cells are believed to contribute to cancer metastasis, the grim process of the disease spreading from its original site to distant tissues. Blood tests that count these cells can help doctors predict how long a patient with widespread cancer will live.
Learn more.
Anti-aging gene identified as tumor suppressor in mice, research finds
Improves understanding of how tumors grow.
New drug cuts risk of deadly transplant side effect in half
Helps prevent graft-versus-host disease.
Cognitive problems may be present before chemotherapy in women with breast cancer
New information about "chemo-brain".
Anti-aging gene identified as tumor suppressor in mice, research finds
A new study sheds more light on how an anti-aging gene suppresses cancer growth, joint going to a new website University of Michigan Health System and going to a new website Harvard Medical School research shows.
Mice that didn't have the SIRT6 protein had larger and more aggressive cancer tumors.
Learn more.
New drug cuts risk of deadly transplant side effect in half
Helps prevent graft-versus-host disease.
Cognitive problems may be present before chemotherapy in women with breast cancer
New information about "chemo-brain".
Ponatinib acts against the most resistant types of chronic myeloid leukemia
Drug is effective after all others fail.
New drug cuts risk of deadly transplant side effect in half
A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant
treatments, according to a study from researchers at the U-M Cancer Center.
Learn more.
Cognitive problems may be present before chemotherapy in women with breast cancer
New information about "chemo-brain".
Ponatinib acts against the most resistant types of chronic myeloid leukemia
Drug is effective after all others fail.
Drug shows promise in prostate cancer spread to bone
Cabozantinib, demonstrated dramatic and positive effects.
